[go: up one dir, main page]

NO20014478D0 - Treatment of certain cancers associated with weight gain - Google Patents

Treatment of certain cancers associated with weight gain

Info

Publication number
NO20014478D0
NO20014478D0 NO20014478A NO20014478A NO20014478D0 NO 20014478 D0 NO20014478 D0 NO 20014478D0 NO 20014478 A NO20014478 A NO 20014478A NO 20014478 A NO20014478 A NO 20014478A NO 20014478 D0 NO20014478 D0 NO 20014478D0
Authority
NO
Norway
Prior art keywords
treatment
weight gain
certain cancers
cancers associated
certain
Prior art date
Application number
NO20014478A
Other languages
Norwegian (no)
Other versions
NO20014478L (en
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20014478D0 publication Critical patent/NO20014478D0/en
Publication of NO20014478L publication Critical patent/NO20014478L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014478A 1999-03-19 2001-09-14 Treatment of certain cancers associated with weight gain NO20014478L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12525099P 1999-03-19 1999-03-19
PCT/US2000/007361 WO2000056323A1 (en) 1999-03-19 2000-03-17 Treatment of certain cancers associated with weight gain

Publications (2)

Publication Number Publication Date
NO20014478D0 true NO20014478D0 (en) 2001-09-14
NO20014478L NO20014478L (en) 2001-10-29

Family

ID=22418838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014478A NO20014478L (en) 1999-03-19 2001-09-14 Treatment of certain cancers associated with weight gain

Country Status (19)

Country Link
EP (1) EP1171106A1 (en)
JP (1) JP2002539255A (en)
KR (1) KR20010113765A (en)
CN (1) CN1399545A (en)
AU (1) AU3632000A (en)
BG (1) BG105998A (en)
BR (1) BR0009161A (en)
CA (1) CA2367045A1 (en)
CZ (1) CZ20013281A3 (en)
HU (1) HUP0200497A2 (en)
IL (1) IL145239A0 (en)
MX (1) MXPA01009470A (en)
NO (1) NO20014478L (en)
NZ (1) NZ514012A (en)
PL (1) PL351958A1 (en)
SK (1) SK13372001A3 (en)
TR (1) TR200102692T2 (en)
WO (1) WO2000056323A1 (en)
ZA (1) ZA200107687B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622600A1 (en) * 2003-04-28 2006-02-08 Cipla Ltd. Pharmaceutical formulation comprising anti-obesity agent and acidulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
KR20010113765A (en) 2001-12-28
HUP0200497A2 (en) 2002-08-28
NZ514012A (en) 2001-09-28
CZ20013281A3 (en) 2002-07-17
BR0009161A (en) 2002-01-22
CN1399545A (en) 2003-02-26
WO2000056323A1 (en) 2000-09-28
AU3632000A (en) 2000-10-09
BG105998A (en) 2002-06-28
NO20014478L (en) 2001-10-29
EP1171106A1 (en) 2002-01-16
CA2367045A1 (en) 2000-09-28
TR200102692T2 (en) 2002-03-21
SK13372001A3 (en) 2002-07-02
MXPA01009470A (en) 2004-03-19
IL145239A0 (en) 2002-06-30
PL351958A1 (en) 2003-07-14
JP2002539255A (en) 2002-11-19
ZA200107687B (en) 2002-12-18

Similar Documents

Publication Publication Date Title
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
IL147643A0 (en) Drug therapy of the restless leg syndrome
PL352993A1 (en) Methods of treating and/or suppressing weight gain
IL157425A0 (en) Treatment of solid tumours with paramycin derivatives
DE60009147T2 (en) ADMANTAN DERIVATIVES
ATE231869T1 (en) PYRIDOPYRANOAZEPINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE
ATE273962T1 (en) 5-PHENYL-PYRIMIDINE DERIVATIVES
NO20015516L (en) Preparations and uses of ET743 for the treatment of cancer
NO20022245L (en) Oncolytic combinations for the treatment of cancer
NO20020358D0 (en) Use of etodolac for the treatment of cancer
ATE317389T1 (en) 4-PHENYL-PYRIMIDINE DERIVATIVES
NO20015738L (en) Therapeutic use of melatonin
NO20014725L (en) Enhanced cancer treatment with temozolomide
PL350919A1 (en) Method of controlling weight gain associated with therapeutic drugs
NO20014478L (en) Treatment of certain cancers associated with weight gain
NO20014845D0 (en) Use of arylalkanoylpyridazines
HK1045252A (en) Treatment of certain cancers associated with weight gain
NO993313L (en) Derivatives of 5-nitrofurfural
GB9911183D0 (en) Treatment of cancers
NO20014476D0 (en) Treatment of hiatial hernia
FI991138A0 (en) Therapeutic use of normobaric hypoxia
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
NO20014093L (en) Treatment of infertility